Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Merck
Deloitte
Cipla
Argus Health
Queensland Health
Harvard Business School
Chinese Patent Office
Fish and Richardson

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: RE36481

« Back to Dashboard

Summary for Patent: RE36481
Title: HMG-CoA reductase inhibitors
Abstract:Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II): ##STR1##
Inventor(s): Inamine; Edward S. (Rahway, NJ), Hensens; Otto D. (Red Bank, NJ), Houck; David R. (Los Alamos, NM), Lee; Ta J. (Lansdale, PA), Smith; Robert L. (Lansdale, PA), Halczenko; Wasyl (Hatfield, PA), Hartman; George D. (Lansdale, PA), Stokker; Gerald E. (Gwynedd Valley, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/188,158
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent RE36481

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent RE36481

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0251625 ➤ Try a Free Trial
Canada 1340452 ➤ Try a Free Trial
Germany 3770345 ➤ Try a Free Trial
Germany 3869282 ➤ Try a Free Trial
Denmark 317287 ➤ Try a Free Trial
Denmark 486088 ➤ Try a Free Trial
Canada 1340331 ➤ Try a Free Trial
European Patent Office 0306263 ➤ Try a Free Trial
Canada 1307263 ➤ Try a Free Trial
Australia 7455987 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Express Scripts
Harvard Business School
Healthtrust
Fish and Richardson
Colorcon
Boehringer Ingelheim
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot